{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:32:17Z","timestamp":1793640737295,"version":"4.5.1"},"reference-count":15,"publisher":null,"issue":"8","license":[{"start":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:00:00Z","timestamp":1630368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/lib.ossn.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kardiologiia"],"abstract":"<jats:p>\n                    <jats:italic>Aim<\/jats:italic>\n                    \u00a0\u00a0\u00a0\u00a0\u00a0 To study the practice of drug treatment of ischemic heart disease (IHD) and the consistency of this practice with the established guidelines.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Material and methods<\/jats:italic>\n                    \u00a0 Results of the Russian part of the EUROASPIRE V study were compared with the general European population of the study. At \u22656 mos. and &lt;2 years after the discharge from the hospital, patients were invited to visit the site for an interview. The drug therapy recommended upon discharge and taken by patients in the long-term as well as the patients\u2019 compliance with the treatment were analyzed. In Russian centers, 699 patients were registered, and 399 of them visited the centers for the interview.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Results<\/jats:italic>\n                    \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Upon discharge from the hospital, patients of the Russian cohort and of the entire study population were prescribed acetylsalicylic acid or other antiplatelet drugs (99.2% and 94.1%, respectively); beta-blockers (87.2 and 81.6%, respectively); angiotensin-converting enzyme (ACE) inhibitors (69.9% and 61.1%, respectively); sartans (16.5% and 14.2\u200a%, respectively); calcium channel blockers (19.3 and 19.4\u200a%, respectively); nitrates (8.0% and 22.5\u200a%, respectively); diuretics (31.1 and 32.5\u200a%, respectively); statins (98.0% and 85.0\u200a%, respectively); and anticoagulants (6.6 and 8.3\u200a%, respectively). For the long-term treatment, patients of the Russian cohort and of the entire study population took antiplatelets (94.7\u200a% and 92.5\u200a%, respectively); beta-blockers (83.2% and 81.0\u200a%, respectively); ACE inhibitors (60.2% and 57.3\u200a%, respectively); sartans (19.3% and 18.4\u200a%, respectively); calcium antagonists (21.1% and 23.0\u200a%, respectively); nitrates (9.0% and 18.2\u200a%, respectively); diuretics (31.8% and 33.3\u200a%, respectively); statins (88.2% and 80.8\u200a%, respectively); and anticoagulants (8.8% and 8.2\u200a%, respectively). High intensity hypolipidemic therapy was prescribed to 54.0\u200a% of patients in Russian centers and 60.3\u200a% of patients in the entire study. Both Russian and international patients evaluated their compliance with the prescribed medication as high.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    \u00a0\u00a0\u00a0\u00a0\u00a0 According to results of the EUROASPIRE V study as compared to earlier studies, the practice of drug therapy in Russian patients with IHD has significantly approached European indexes. Further optimization is possible by a more extensive use of high intense hypolipidemic treatment and antidiabetic drugs with a documented positive effect on prognosis of cardiovascular diseases.\n                  <\/jats:p>","DOI":"10.18087\/cardio.2021.8.n1650","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T05:26:41Z","timestamp":1632288401000},"page":"4-13","source":"Crossref","is-referenced-by-count":9,"title":["Drug Therapy and Adherence in Patients With Coronary Heart Disease: Results of the Russian Part of the EUROASPIRE V International Multicenter Study"],"prefix":"10.68900","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4165-804X","authenticated-orcid":true,"given":"N. V.","family":"Pogosova","sequence":"first","affiliation":[{"name":"National Medical Research Center of Cardiology of the Ministry of Health of Russian Federation, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6998-8406","authenticated-orcid":true,"given":"S. A.","family":"Boytsov","sequence":"additional","affiliation":[{"name":"National Medical Research Center of Cardiology of the Ministry of Health of Russian Federation, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9794-7484","authenticated-orcid":true,"given":"A. K.","family":"Ausheva","sequence":"additional","affiliation":[{"name":"National Medical Research Center of Cardiology of the Ministry of Health of Russian Federation, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. Y.","family":"Sokolova","sequence":"additional","affiliation":[{"name":"National Medical Research Center of Cardiology of the Ministry of Health of Russian Federation, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1577-3623","authenticated-orcid":true,"given":"A. A.","family":"Arutyunov","sequence":"additional","affiliation":[{"name":"National Medical Research Center of Cardiology of the Ministry of Health of Russian Federation, Moscow"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6845-6173","authenticated-orcid":true,"given":"I. V.","family":"Osipova","sequence":"additional","affiliation":[{"name":"Krai government-owned publicly funded health care institution \u201cRegional clinical hospital\u201d, Barnaul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0879-0946","authenticated-orcid":true,"given":"Yu. M.","family":"Pozdnyakov","sequence":"additional","affiliation":[{"name":"Budgetary Public Health Facility of the Moscow Region \u201cZhukovsky city clinical hospital\u201d, Zhukovsky"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":null,"published-online":{"date-parts":[[2021,8,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). European Heart Journal. 2016;37(29):2315\u201381. DOI: 10.1093\/eurheartj\/ehw106","DOI":"10.1093\/eurheartj\/ehw106"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, FunckBrentano C et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal. 2020;41(3):407\u201377. DOI: 10.1093\/eurheartj\/ehz425","DOI":"10.1093\/eurheartj\/ehz425"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Sommet A, Pariente A. Methods in pharmacoepidemiology. Therapies. 2019;74(2):187\u201397. DOI: 10.1016\/j.therap.2018.11.015","DOI":"10.1016\/j.therap.2018.11.015"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Kotseva K, Wood D, De Backer G, De Bacquer D, Py\u00f6r\u00e4l\u00e4 K, Keil U et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. European Journal of Cardiovascular Prevention and Rehabilitation. 2009;16(2):121\u201337. DOI: 10.1097\/HJR.0b013e3283294b1d","DOI":"10.1097\/HJR.0b013e3283294b1d"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Kotseva K, Wood D, De Bacquer D, De Backer G, Ryd\u00e9n L, Jennings C et al. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. European Journal of Preventive Cardiology. 2016;23(6):636\u201348. DOI: 10.1177\/2047487315569401","DOI":"10.1177\/2047487315569401"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Pogosova N.V., Oganov R.G., Boytsov S.A., Ausheva A.K., Sokolova O.Yu., Kursakov A.A. et al. Secondary prevention in patients with coronary artery disease in Russia and Europe: results from the Russian part of the EUROASPIRE V survey. Cardiovascular Therapy and Prevention. 2020;19(6):67\u201378. DOI: 10.15829\/1728-8800-2020-2739","DOI":"10.15829\/1728-8800-2020-2739"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Kotseva K, De Backer G, De Bacquer D, Ryd\u00e9n L, Hoes A, Grobbee D et al. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. European Journal of Preventive Cardiology. 2019;26(8):824\u201335. DOI: 10.1177\/2047487318825350","DOI":"10.1177\/2047487318825350"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Pogosova N.V., Oganov R.G., Boytsov S.A., Ausheva A.K., Sokolova O.Yu., Pozdnyakov Yu.M. et al. Drug Treatment of Patients With Ischemic Heart Disease in Russia and Europe: Results of Russian Part of the International Multicenter Study EUROASPIRE IV. Kardiologiia. 2016;56(12):11\u20139.","DOI":"10.18087\/cardio.2019.12.n740"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Michniewicz E, Mlodawska E, Lopatowska P, Tomaszuk-Kazberuk A, Malyszko J. Patients with atrial fibrillation and coronary artery disease - Double trouble. Advances in Medical Sciences. 2017;63(1):30\u20135. DOI: 10.1016\/j.advms.2017.06.005","DOI":"10.1016\/j.advms.2017.06.005"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal. 2020;41(2):255\u2013323. DOI: 10.1093\/eurheartj\/ehz486","DOI":"10.1093\/eurheartj\/ehz486"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Dedov I.I., Shestakova M.V., Mayorov A.Yu., Vikulova O.K., Galstyan G.R., Kuraeva T.L. et al. Standards of specialized diabetes care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 9th edition. Diabetes mellitus. 2019;22(S1-1):1\u2013144. DOI: 10.14341\/DM221S1","DOI":"10.14341\/DM221S1"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Althubaiti A. Information bias in health research: definition, pitfalls, and adjustment methods. Journal of Multidisciplinary Healthcare. 2016;9:211\u20137. DOI: 10.2147\/JMDH.S104807","DOI":"10.2147\/JMDH.S104807"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Davidovich I.M., Malay L.N., Kutishenko N.P. The analysis of long-term outcomes and adherent to treatment in patients after myocardial infarction: Khabarovsk Register Data. The Clinician. 2017;11(1):36\u201344. DOI: 10.17650\/1818-8338-2016-10-4-36-44","DOI":"10.17650\/1818-8338-2016-10-4-36-44"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Erlikh A.D., Gratsiansky N.A. Registry of Acute Coronary Syndromes \u2018RECORD-3\u2019. Characteristics of Patients and Treatment During Initial Hospitalization. Kardiologiia. 2016;56(4):16\u201324. DOI: 10.18565\/cardio.2016.4.16-24","DOI":"10.18565\/cardio.2016.4.16-24"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Erlikh A.D. Changes of Treatment of Patients With Non-ST Elevation Acute Coronary Syndrome in Clinical Practice During Recent Several Years (Data From a Series of the Russian RECORD Registries). Kardiologiia. 2018;58(12):13\u201321. DOI: 10.18087\/cardio.2018.12.10189","DOI":"10.18087\/cardio.2018.12.10189"}],"container-title":["Kardiologiia"],"original-title":[],"link":[{"URL":"https:\/\/lib.ossn.ru\/jour\/article\/viewFile\/1650\/1032","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:17:57Z","timestamp":1793639877000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.elpub.ru\/jour\/article\/view\/1650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,31]]},"references-count":15,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,31]]}},"URL":"https:\/\/doi.org\/10.18087\/cardio.2021.8.n1650","relation":{},"ISSN":["2412-5660","0022-9040"],"issn-type":[{"value":"2412-5660","type":"electronic"},{"value":"0022-9040","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,31]]}}}